熱門資訊> 正文
诺和诺德告诉一些员工接受降职或失业
2025-09-30 22:10
- 諾和諾德(NVO) 0
- 塞拉尼斯(CE) 0
- LifeMD(LFMD) 0
- Novo Nordisk (NVO), which is down ~36% year-to-date, is giving some employees a choice: Accept a demotion with lower pay or receive a pink slip.
- Some workers were given just 24 hours to proceed with a demotion or take a severance package, Bloomberg reported.
- Danish newspaper Borsen said that impacted employees who stay on would face reduction in pay, as well as potential reassignments and loss of management responsibilities.
- Earlier in September, as part of a broader restructuring ordered by new CEO Maziar Mike Doustdar, the company's U.S. sales team focused on obesity and diabetes education for healthcare providers, known as cardiometabolic educators, was being let go.
More on Novo Nordisk
- The Truth About Novo Nordisk: 4 Myths That Don't Hold Up
- Novo Nordisk: Wegovy Sales Soar, Trump Tariffs No Threat
- Novo Nordisk: Don't Be Deterred By Outlook Downgrades
- LifeMD expands Novo Nordisk partnership to offer Ozempic
- Novo Nordisk downgraded at Morgan Stanley on weight loss drug competition
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
